Estée Lauder Earnings Call Signals Profitable Turnaround
I'm LongbridgeAI, I can summarize articles.Estée Lauder reported a Q4 earnings call signaling a profitable turnaround with 3% organic sales growth and significant margin expansion. Diluted EPS rose 66% to $2.51, driven by strong performance in Fragrance, Skin Care, and China. The company raised its fiscal 2027 outlook, forecasting 3-5% organic sales growth and an operating margin of 12.7%-13.5%. However, challenges remain, including restructuring charges, underperforming Hair Care, and regional headwinds in the Middle East.
Estée Lauder ((EL)) has held its Q4 earnings call. Read on for the main highlights of the call.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Estée Lauder’s latest earnings call struck a cautiously upbeat tone, signaling a return to organic growth and a clear step-change in profitability. Management highlighted stronger margins, sharply higher EPS, and solid cash generation, supported by momentum in online, Fragrance, and China. At the same time, they emphasized that restructuring charges and uneven category performance remain meaningful near‑term hurdles.
Return to Organic Growth
Estée Lauder reported a 3% rise in organic net sales for fiscal 2026, with reported sales up 5% and positive sales performance in every quarter. Management underscored that growth was sequentially improving across most brands and regions, marking a turning point after a period of stagnation.
Significant Margin Expansion and EPS Growth
Profitability improved markedly, with gross margin expanding 150 basis points for the year and 360 basis points in Q4 to 75.5%. Operating margin rose 320 basis points to 11.2%, helping drive diluted EPS up 66% to $2.51 for the year, while Q4 EPS jumped to $0.39 from $0.09 a year earlier.
Strong Cash Generation and Balance Sheet
Operating cash flow climbed to $1.8 billion from $1.3 billion, reflecting better earnings quality and tighter working capital management. CapEx was kept disciplined at $457 million, down from $602 million, leaving Estée Lauder with a solid $3.5 billion cash position at year-end.
Portfolio Milestones and Brand Momentum
The portfolio hit key milestones as Jo Malone London and TOM FORD became billion-dollar brands, joining Clinique, Estée Lauder, La Mer and M·A·C. The Ordinary delivered another year of double-digit organic growth and is rapidly scaling toward billion‑dollar status, reinforcing the depth of the brand lineup.
Category Strength — Fragrance and Skin Care
Fragrance remained the standout category with 10% organic sales growth, cementing its role as a core profit engine. Skin Care grew 4% organically, with strength from entry-level brand The Ordinary, prestige names like Estée Lauder, and luxury player La Mer, showing resilience across price tiers.
Channel and Innovation Achievements
Online sales increased by double digits and now account for 34% of reported sales, up three points year-over-year and reaching a record mix. Innovation contributed 23% of fiscal 2026 sales, and management plans to lift that contribution by another 200–250 basis points in fiscal 2027 to keep the pipeline fresh.
Regional Performance — China and Travel Retail Recovery
Mainland China led the geographic recovery with broad-based 9% organic sales growth, signaling healthier demand in a critical market. Travel retail returned to growth and now represents about 15% of reported sales, with particular momentum in Hainan, Korea and other Asia-Pacific locations.
Operational Transformation and PRGP Progress
The Beauty Reimagined program and Profit Recovery and Growth Plan delivered benefits faster than expected, enabling a leaner organization with fewer layers and clearer accountability. Digital efforts accelerated, including a Shopify rollout for M·A·C’s U.S. brand.com, while about 80% of enterprise business services roles are slated to transition by September.
Raised Fiscal 2027 Profitability Outlook
Management raised its preliminary fiscal 2027 outlook, guiding organic net sales growth of 3% to 5% and an operating margin of 12.7% to 13.5%. Diluted EPS is forecast between $3.10 and $3.35, signaling confidence that operating leverage and PRGP savings can drive another year of margin expansion.
Restructuring Charges and Cash Impact
The turnaround is not cost-free, with $823 million of cumulative PRGP charges booked in fiscal 2026, largely tied to employees. As a result, net cash from operations is expected to fall to $1.3–$1.4 billion in fiscal 2027, reflecting higher restructuring payments and increased working capital needs.
Profitability Concentration
Management acknowledged that profits remain heavily concentrated in Skin Care and Asia, leaving other areas lagging despite progress. Efforts are ongoing to improve profitability in Makeup, Hair Care and parts of Fragrance, which are not yet contributing in line with the broader portfolio.
Hair Care Still Underperforming
Hair Care remains a weak spot, with the category still not back to organic sales growth for the year. While Aveda is showing early signs of a U.S. turnaround, overall performance in Hair Care is negative and a clear focus area for improvement.
Regional Headwinds — Middle East / EUKEM
Business disruptions tied to conflict in the Middle East reduced EUKEM region growth by roughly 2% in fiscal 2026. Management noted this remains a source of uncertainty, even though they currently do not expect a material impact on fiscal 2027 results.
Short-Term Incentive and SG&A Volatility
Nonconsumer-facing costs were cut in every quarter except Q4, when better-than-expected results triggered higher employee incentives. That drove SG&A up in the quarter, highlighting how variable compensation can add short-term volatility even as the overall cost base is being streamlined.
Guidance Range Includes Lower-End Risk
The fiscal 2027 organic sales guidance of 3%–5% embeds some downside risk, with the lower end implying only modest acceleration versus 2026. Management stressed that the midpoint and upper end reflect stronger upside, but investors will need to watch execution carefully within this broad range.
Forward-Looking Guidance and Profit Path
Looking ahead, Estée Lauder expects 3%–5% organic net sales growth in fiscal 2027, with stronger momentum in the first half and EUKEM improving later in the year. The company sees operating margin rising to 12.7%–13.5%, modest gross-margin gains, and SG&A leverage from PRGP setting the stage for further profitability into fiscal 2028 despite a temporary dip in cash flow.
Estée Lauder’s earnings call painted a picture of a business back on a growth and margin recovery track, powered by Fragrance, Skin Care, China and online channels. Restructuring charges, Hair Care weakness and regional disruptions remain watch points, but raised margin targets and a clearer profit roadmap suggest management believes the heavy lifting of the turnaround is well underway.
